Skip Ribbon Commands
Skip to main content
SharePoint

TMBNCT

Welcome to the SharePoint site for the 
Virtual Technical Meeting on Advances in Boron Neutron Capture Therapy
EVT1905174

The meeting report of this TM is here


FAQ
1) How do I add audio and annotations to my presentation? Click here: MP4 PPTX. For the pptx file, put it into presentation mode to hear the audio!
2) How do I upload my presentation [Remember: 250 Mb/file limit]? Click here: MP4 PPTX. For the pptx file, put it into presentation mode to hear the audio!  
3) How do I use the Discussion Boards? Click here: MP4 PPTXFor the pptx file, put it into presentation mode to hear the audio!  

Introduction 

Accelerator-based boron neutron capture therapy (BNCT) has become available for hospitals and there is a rapidly growing interest from the medical community in using it as innovative modality in oncology. Through biological targeting, BNCT offers an approach to overcoming radiation resistance in some types of cancer, as well as a potential cure for locally recurrent solid tumors after maximal conventional therapies. Clinical experience collected in several hundred patients, especially in Finland and Japan, has generated a multitude of activities for hospital-based BNCT centres. In Japan, there are already three facilities treating patients; in Finland, a facility is being commissioned in Helsinki. Scientific societies have been founded on an international and national (Finland, Germany and Japan) level and accelerator-based high intensity epithermal neutron sources have become available. However, the standardization needed for the further development of this modality is lacking. Practical experience of how to plan, execute and hand over an operating BNCT facility, especially to an institution or in a country that has never operated one before, has not yet been gathered together in one place.

Objectives 

The purpose of the event is to assess the current status of the boron neutron capture therapy technique with emphasis on usage of compact accelerator based intense neutron sources. The event also aims to contribute to the update of IAEA-TECDOC-1223.

Target Audience

The event is aimed at staff from hospitals interested in establishing such a facility; specialists in the process of planning or executing such a project; medical and other scientists performing research and patient treatments for and with BNCT; companies designing and marketing accelerators and beam delivery systems; national standards laboratories in charge of neutron metrology; and regulators. 

Expected Outputs

The expected output of the event will be a report that covers the developments in the field that have taken place since the publication of Current Status of Neutron Capture Therapy (IAEA-TECDOC-1223), in 2001. The report will give a high-level overview of the standards that need to be developed, as well as the processes and considerations required during project development, execution and handover to operations.

Structure 

Due to Covid-19, the meeting was re-organized to be virtual. Talks will be available 2-weeks prior to the meeting. Discussion threads are provided for each talk where you may leave questions and comments. A separate single discussion thread is given for each day.

Topics 

The event will cover topics that form the conceptual table of contents for the final report. They are sorted into the days that will be dealt with in the Webex meeting.
Click on the day of your interest and to find your abstract and contributions. The Lead authors for various sections have now been identified.

​TECDOC section
Lead Authors
​Day
​Prerequisites for neutron beam parameters
Iiro Auterninen, Ignacio Porras, David Nigg, Yuan Hao LiuMonday
​Beam design considerations
Hiroaki Kumada, Jacek Capala
Monday
​Physical dosimetry: determination of beam parameters
Hiroki Tanaka, Daniel SantosMonday
​Neutron sources for BNCT treatment facilities
Yoshiaki Kiyanagi, Andres KreinerTuesday
Organization, operation & management of a treatment facility
Koji Ono, Yoshihiro TakaiTuesday
Treatment facility design
Liisa Porra, Akira Matsumura Satoshi NakamuraTuesday
Regulatory aspects
Sandro Rossi, Noah Smick, Shin MasuiTuesday
​Boron compounds
Evamarie Hey-Hawkins, Hiroyuki Nakamura, Amirreza Jalilian (IAEA)Wednesday
​Radiobiology
Saverio Altieri, Susana Nievas,
Jun Hatazawa
​Wednesday
​Boron concentration determination and imaging
Hanna Koivunoro, Yoshinori SakuraiWednesday
​Prescribing and treatment planning for BNCT
Wolfgang Sauerwein, Shin-Ichi Miyatake
Thursday
​Dose reporting in BNCT
Mandy Schwint – Mitsuko MasutaniThursday
​Clinical trial design and procedures for BNCT
Andrea Wittig, Hiroshi IgakiThursday
Models of dose calculation in BNCT
Sara J. González, Silva Bortolussi,Tatsuhiko Sato​Thursday
​Meeting wrap up and plan for TECDOC development
Friday